Compare CYCN & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYCN | NVVE |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.2M |
| IPO Year | N/A | N/A |
| Metric | CYCN | NVVE |
|---|---|---|
| Price | $1.66 | $0.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 110.0M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,855,000.00 | ★ $4,630,156.00 |
| Revenue This Year | N/A | $892.33 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1371.65 | N/A |
| 52 Week Low | $1.28 | $0.15 |
| 52 Week High | $9.47 | $5.02 |
| Indicator | CYCN | NVVE |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 45.17 |
| Support Level | $1.48 | $0.17 |
| Resistance Level | $1.60 | $0.29 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 93.75 | 8.65 |
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.